Repurposing of Bromocriptine for Cancer Therapy
Bromocriptine is an ergot alkaloid and dopamine D2 receptor agonist used to treat Parkinson’s disease, acromegaly, hyperprolactinemia, and galactorrhea, and more recently diabetes mellitus. The drug is also active against pituitary hormone-dependent tumors (prolactinomas and growth-hormone producing...
Main Authors: | Ean-Jeong Seo, Yoshikazu Sugimoto, Henry Johannes Greten, Thomas Efferth |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2018-10-01
|
Series: | Frontiers in Pharmacology |
Subjects: | |
Online Access: | https://www.frontiersin.org/article/10.3389/fphar.2018.01030/full |
Similar Items
-
Bromocriptine monotherapy overcomes prostate cancer chemoresistance in preclinical models
by: Lijuan Bai, et al.
Published: (2023-08-01) -
Incidence of heart valve disease in women treated with the ergot-derived dopamine agonist bromocriptine
by: Marianne F. Clausen, et al.
Published: (2021-12-01) -
Kinetic profiling an abundantly expressed planarian serotonergic GPCR identifies bromocriptine as a perdurant antagonist
by: John D. Chan, et al.
Published: (2016-12-01) -
Co-Administration of Curcumin and Bromocriptine Nano-liposomes for Induction of Apoptosis in Lung Cancer Cells
by: Mojgan Sheikhpour, et al.
Published: (2020-01-01) -
A Case Report of Trigeminal Neuralgia after Taking Bromocriptine
by: Reza Bavarsad Shahripour
Published: (2011-07-01)